In addition, the immunosuppressive status of insufficient TNF-α and IFN-γ expression did not change in PD-1–expressing Trms from HBV-related HCC patients after phorbol myristate acetate (PMA)/ionomycin stimulation (35). The gene discussed is PDCD1; the disease is hepatocellular carcinoma.